通化金马：公司新药目前已完成各项专业审评工作，进入综合审评环节，临近审批阶段

Core Viewpoint - The company Tonghua Golden Horse has provided an update on the approval status of its new drug, indicating that it has completed all professional review work and is now in the comprehensive review stage, nearing the approval phase [2]. Summary by Categories - Drug Approval Progress - The new drug, Amber Dihydroaminoacridine Tablets, has completed all necessary professional review work and is currently in the comprehensive review stage, approaching the approval phase [2]. - The company advises stakeholders to refer to the public information from the drug review center for the latest updates on the drug's review progress [2]. - The company will disclose any information that meets the disclosure standards as per relevant regulations if significant events occur [2].